Traditionally, New Year’s resolutions to lose weight involve getting to the gym more. In a post-GLP-1 world, that’s looking less necessary.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
It’s just another earnings week in the life of pharmaceutical CEOs, with blockbuster expectations running up against cruel reality.
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
The Food and Drug Administration declared an end to the scarcity of Eli Lilly’s highly in-demand weight-loss and diabetes drugs on Thursday.
In the obesity drug industry, two players have really been throwing their weight around. There isn’t a third in sight.
The deal puts an end to Fubo’s ongoing lawsuit that sought to block Disney’s efforts to build Venu Sports with Fox and Warner Bros. Discovery.
Record earnings from Foxconn and some fresh tariff news highlight core themes likely to dominate headlines this year.
People who work on Wall Street face a more quotidian challenge starting this morning: getting there, thanks to New York’s congestion pricing.